Literature DB >> 23205104

The expression of KIT receptor dimers in gastrointestinal stromal tumors independent of c-kit mutation and SCF expression is associated with high-risk stratification.

Cen Qiu1, Xiaohong Liu, Chenguang Bai, DA Lie Ma.   

Abstract

Although the dimerization of KIT, a receptor tyrosine kinase, plays a major role in a number of tumors, correlations between the clinicopathological parameters and KIT receptor dimers have not been identified. In the current study, a method for the detection of KIT receptor dimer expression was described and correlations between the clinicopathological parameters and KIT receptor dimers were analyzed. A single center cohort study of 49 patients with gastrointestinal stromal tumors (GISTs) was conducted to analyze the expression of KIT receptor dimers by SDS-PAGE, Native-PAGE and modified Native-PAGE. Immunohistochemistry was used to examine the expression of ki-67, c-kit and stem cell factor (SCF). Mutations of the c-kit gene were examined in 48 GISTs according to the polymerase chain reaction (PCR) and direct sequencing methods. Based on the data, a signal for the KIT receptor monomer was obtained by SDS-PAGE. Faint bands were observed on the nitrocellulose membrane by Native-PAGE, while clear bands were identified for KIT receptor dimers and monomers using modified Native-PAGE (15 out of 49 cases). The tumor size was larger in KIT receptor dimer-positive cases compared with that in KIT receptor dimer-negative cases. Analysis of KIT receptor dimer expression levels and risk stratification demonstrated that KIT receptor dimer-positive cases belonged to the higher risk classification. In addition, there was no significant correlation between the existence of KIT receptor dimers and c-kit gene mutations, including SCF expression. In conclusion, this study established a method for the detection of the existence of KIT receptor dimers in tissues and confirmed that KIT receptor dimers were correlated with risk stratification. Data also indicated that ligand-dependent SCF/KIT dimerization is an independent crucial mechanism in GIST cell proliferation and increases the risk of GIST. Therefore, blocking KIT dimerization may prove to be an effective approach for the treatment of GISTs.

Entities:  

Year:  2012        PMID: 23205104      PMCID: PMC3506609          DOI: 10.3892/ol.2012.797

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  24 in total

Review 1.  Staining for enzymatic activity after gel electrophoresis, I.

Authors:  O Gabriel; D M Gersten
Journal:  Anal Biochem       Date:  1992-05-15       Impact factor: 3.365

Review 2.  Signal transduction by receptors with tyrosine kinase activity.

Authors:  A Ullrich; J Schlessinger
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

3.  Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors.

Authors:  Y Yarden; J A Escobedo; W J Kuang; T L Yang-Feng; T O Daniel; P M Tremble; E Y Chen; M E Ando; R N Harkins; U Francke
Journal:  Nature       Date:  1986 Sep 18-24       Impact factor: 49.962

4.  Starch gel electrophoresis of enzymes--a compilation of recipes.

Authors:  C R Shaw; R Prasad
Journal:  Biochem Genet       Date:  1970-04       Impact factor: 1.890

5.  Expression of protooncogene c-kit and its ligand stem cell factor (SCF) in gastric carcinoma cell lines.

Authors:  S Hassan; Y Kinoshita; C Kawanami; K Kishi; Y Matsushima; A Ohashi; Y Funasaka; A Okada; T Maekawa; W He-Yao; T Chiba
Journal:  Dig Dis Sci       Date:  1998-01       Impact factor: 3.199

6.  Expression of c-kit and kit ligand in human colon carcinoma cells.

Authors:  M Toyota; Y Hinoda; A Takaoka; Y Makiguchi; T Takahashi; F Itoh; K Imai; A Yachi
Journal:  Tumour Biol       Date:  1993

7.  Expression of stem cell factor and c-kit in human neuroblastoma. The Children's Cancer Group.

Authors:  P S Cohen; J P Chan; M Lipkunskaya; J L Biedler; R C Seeger
Journal:  Blood       Date:  1994-11-15       Impact factor: 22.113

8.  Activation of the human c-kit product by ligand-induced dimerization mediates circular actin reorganization and chemotaxis.

Authors:  P Blume-Jensen; L Claesson-Welsh; A Siegbahn; K M Zsebo; B Westermark; C H Heldin
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

9.  Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand.

Authors:  Y Yarden; W J Kuang; T Yang-Feng; L Coussens; S Munemitsu; T J Dull; E Chen; J Schlessinger; U Francke; A Ullrich
Journal:  EMBO J       Date:  1987-11       Impact factor: 11.598

10.  Primary structure of c-kit: relationship with the CSF-1/PDGF receptor kinase family--oncogenic activation of v-kit involves deletion of extracellular domain and C terminus.

Authors:  F H Qiu; P Ray; K Brown; P E Barker; S Jhanwar; F H Ruddle; P Besmer
Journal:  EMBO J       Date:  1988-04       Impact factor: 11.598

View more
  2 in total

1.  MicroRNA-218 inhibits gastrointestinal stromal tumor cell and invasion by targeting KIT.

Authors:  Rong Fan; Jie Zhong; Sichang Zheng; Zhengting Wang; Ying Xu; Shuyi Li; Jie Zhou; Fei Yuan
Journal:  Tumour Biol       Date:  2013-12-29

2.  Frequency of KIT Mutation in Gastrointestinal Stromal Tumors According to Histologic and Immunohistochemical Findings, the First Report from Iran.

Authors:  Bita Geramizadeh; Zahra Jowkar; Zeinab Ranjbar
Journal:  Iran J Med Sci       Date:  2015-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.